1. Estimated human absorbed dose for ⁶⁸Ga-ECC based on mice data: comparison with ⁶⁷Ga-ECC

   • Saeed Shanehsazzadeh
   • Hassan Yousefnia
   • Afsaneh Lahooti

   Original Article 31 March 2015 Pages: 475 - 481

   

2. Role of ⁶⁴CuCl₂ PET/CT in staging of prostate cancer

   • Enza Capasso
   • Silvia Durzu
   • Siroos Mirzaei

   Original Article 02 April 2015 Pages: 482 - 488

   

3. Impact of residual ¹⁸F-fluoride in ¹⁸F-FDOPA for the diagnosis of neuroblastoma

   • Ya-Yao Huang
   • Kai-Yuan Tzen
   • Chyng-Yann Shiue

   Original Article 08 April 2015 Pages: 489 - 498

   

4. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands

   • Azusa Tokue
   • Tetsuya Higuchi
   • Yoshito Tsushima

   Original Article 16 April 2015 Pages: 499 - 505

   

5. Optimized production and quality control of ⁶⁸Ga-EDTMP for small clinical trials

   • Alireza Mirzaei
   • Amir R. Jalilian
   • Davood Beiki

   Original Article 23 April 2015 Pages: 506 - 511

   

6. Additional information gained by positron emission tomography with ⁶⁸Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors

   • Yuji Nakamoto
   • Kohei Sano
   • Kaori Togashi

   Original Article Open access 18 April 2015 Pages: 512 - 518

   

7. ^99mTc-3PRGD₂ SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab

   • Qingjie Ma
   • Kaiyin Min
   • Shi Gao

   Original Article 25 April 2015 Pages: 519 - 527

   

8. Ventilation/perfusion SPECT or SPECT/CT for lung function imaging in patients with pulmonary emphysema?

   • Vera Froeling
   • Uwe Heimann
   • Nils F. Schreiter

   Original Article 05 May 2015 Pages: 528 - 534

   

9. [¹⁸F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study

   • Eliot T. McKinley
   • Jennifer M. Watchmaker
   • H. Charles Manning

   Original Article 22 April 2015 Pages: 535 - 542

   

10. Draft guidelines regarding appropriate use of ¹³¹I-MIBG radiotherapy for neuroendocrine tumors

    • Seigo Kinuya
    • Keiichiro Yoshinaga
    • Hiroshi Kawamoto

    Others 14 March 2015 Pages: 543 - 552